Blog
    Peptide SpotlightFor PatientsSeptember 27, 2026

    Ipamorelin vs Sermorelin: Choosing a Growth Hormone Peptide

    Compare Ipamorelin and Sermorelin to see how these growth hormone secretagogues differ in safety, FDA status, and clinical research for your health goals.

    If you are looking into growth hormone secretagogues (which is just a fancy way of saying things that tell your body to make its own growth hormone), you have likely run into these two names. They both want to do the same thing, but they go about it in slightly different ways.

    The Old Pro: Sermorelin

    Sermorelin has a [Grade: B+] and is basically the grandparent of this group. It was actually FDA-approved back in 1990 for testing and later for treating children who were not making enough growth hormone.

    Here is how it works: it is an analog of GHRH. That stands for Growth Hormone Releasing Hormone. It talks to your pituitary gland (the little pea-sized organ in your brain that controls hormones) to get things moving.

    One of the best things about Sermorelin is that it plays by the rules. It preserves your body's natural feedback loop. This means it respects your body's "stop" signals, which helps prevent your growth hormone levels from getting too high.

    The Highlights:

    • It was FDA-approved (though the original maker stopped producing it in 2008 because of supply issues, not because it was unsafe).
    • It has two completed studies showing positive results for cognition, which is your ability to think and process information.
    • It keeps your natural rhythms intact.

    The New Specialist: Ipamorelin

    Ipamorelin has a [Grade: B-] and is a bit more targeted. It is a selective pentapeptide. That means it is a small chain of proteins designed to do exactly one job: trigger short bursts of growth hormone.

    Unlike older versions of these compounds, Ipamorelin is very picky. It does not mess with cortisol (your stress hormone) or prolactin (a hormone involved in milk production). It just focuses on growth hormone pulses that last about two hours when given through a vein.

    The Highlights:

    • It is highly selective, meaning it won't accidentally trigger other hormones you aren't trying to change.
    • It mimics the natural way your body releases hormones in pulses rather than a constant, steady stream.
    • It completed Phase II clinical trials for stomach issues, though it failed to meet the final goals for that specific use.

    What we don't know (and it is quite a bit)

    Scientists are still working on this one—turns out the human body is complicated. Who knew?

    For sermorelin, we lack large-scale studies in adults. One study on aging only had 19 people in it, which is not exactly a crowd. Since the original company stopped making it, no one is really paying for big new trials.

    Ipamorelin has even more question marks. There are zero published human trials proving it helps with body composition, losing fat, or athletic performance. Also, if you have heard of people mixing it with something called CJC-1295, you should know there is zero clinical evidence for that specific combination. The FDA has also flagged some safety concerns regarding how it is made in compounding pharmacies.

    Which one is right for you?

    This is a great one to bring up with your doctor. If you are curious about how to find a peptide prescriber who understands the difference between a GHRH analog and a ghrelin receptor agonist, we can help.

    You can find peptide-experienced physicians in our Find a Doctor directory. Learning how to find a peptide prescriber is the best first step toward figuring out which of these fits your specific needs.

    This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.

    Referenced Peptides

    This content was generated from TruthTides clinical reference data. It does not constitute medical advice. Always consult a qualified healthcare provider.